Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding. (Q36688987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

review article

1 reference

title

Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

4

Nicola Ragni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Francesca Esposito

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Stefano Pretta

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

1823-1831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

Defining the clinical course of multiple sclerosis: Results of an international survey

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Multiple sclerosis genetics: leaving no stone unturned

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

A population-based study of multiple sclerosis in twins: update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Progress in deciphering the genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Age-adjusted recurrence risks for relatives of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Frequent association of multiple sclerosis with varicella and zoster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Recent use of oral contraceptives and the risk of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Sexuality in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Safety of magnetic resonance imaging contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Pregnancy and multiple sclerosis: the children of PRIMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Pregnancy, delivery, and birth outcome in women with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

The mechanism of action of methylprednisolone in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Interferon therapy in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

The efficacy of azathioprine in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Azathioprine therapy for patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Inflammatory bowel disease: management issues during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Mitoxantrone treatment of multiple sclerosis: safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Mitoxantrone in progressive multiple sclerosis: when and how to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Other therapy options and future strategies for treating patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Emerging therapies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Uncrossed cortico-muscular projections in humans are abundant to facial muscles of the upper and lower face, but may differ between sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Planned vaginal births in women with multiple sclerosis: delivery and birth outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Clearance of compounds of different molecular size in the human placenta in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.12.1823

10.1586/14737175.6.12.1823

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17181429%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference